GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (FRA:6CQ) » Definitions » Additional Paid-In Capital

Cresco Labs (FRA:6CQ) Additional Paid-In Capital : €89.4 Mil(As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Cresco Labs Additional Paid-In Capital?


Cresco Labs's quarterly additional paid-in capital increased from Mar. 2024 (€76.2 Mil) to Jun. 2024 (€93.8 Mil) but then stayed the same from Jun. 2024 (€93.8 Mil) to Sep. 2024 (€89.4 Mil).

Cresco Labs's annual additional paid-in capital increased from Dec. 2021 (€0.0 Mil) to Dec. 2022 (€82.6 Mil) but then declined from Dec. 2022 (€82.6 Mil) to Dec. 2023 (€76.0 Mil).

Cresco Labs Additional Paid-In Capital Historical Data

The historical data trend for Cresco Labs's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs Additional Paid-In Capital Chart

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.28 - - 82.64 76.04

Cresco Labs Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 76.04 76.20 93.77 89.40

Cresco Labs Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Cresco Labs Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Cresco Labs's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Cresco Labs Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (FRA:6CQ) » Definitions » Additional Paid-In Capital
Comparable Companies
TSX:GUD TSX:WEED TSX:CPH TSX:DHT.U TSX:ACB NEOE:VRNO TSX:TSND NEOE:GLAS.A.U TSX:OGI XCNQ:GRIN ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XSWX:SDZ XTAE:TEVA NSE:DIVISLAB VTRS
Traded in Other Exchanges
CRLBF:USA CL:Canada
Address
400 West Erie Street, Suite 110, Chicago, IL, USA, 60654
Website
https://www.crescolabs.com
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and others. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.

Cresco Labs Headlines

No Headlines